Dangerous Drugs & Devices Archives

Supreme Court issues opinion reversing $21 million award in Mutual Pharmaceutical Co., Inc. v. Bartlett

On June 24, 2013, the Supreme Court reversed a $21 million jury verdict awarded to a woman who suffered serious and debilitating…

FDA takes steps to tighten restrictions on metal-on-metal hip implants

On January 17, 2013, the U.S. Food and Drug Administration (FDA) issued new safety information and recommendations to patients and health care…

Additional concerns emerge as fungal meningitis outbreak expands

The fungal meningitis outbreak, linked to contaminated steroids produced and distributed by New England Compounding Center (NECC), has grown to 214 cases…

New warnings issued on hip resurfacing procedures

A recent study appearing in the online version of The Lancet warns of increased early failure rates for hip resurfacing implants. The…

Plaintiffs seek consolidation of state court Stryker hip cases

On September 19, 2012, attorneys representing plaintiffs who have been injured by the Stryker Rejuvenate and ABG II modular hip implant devices…

Fungal meningitis outbreak raises safety concerns over compounding pharmacies

Health officials across the country are investigating an outbreak of fungal meningitis that has resulted in eight deaths. As of Monday, October…

MDL created for Biomet M2a lawsuits

The United States Judicial Panel on Multidistrict Litigation (JPML) issued an order on October 2, 2012 transferring eight product liability cases involving…